Home
>
US Stocks
>
Merus N.V
Merus N.V
MRUS

Merus N.V (MRUS)

$25.930.42%

  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open$25.78
Today Low/High$25.28 / $26.62
52 Week Low/High$16.14 / $33.09
Market Cap$1.03B

Company Details

Merus is a clinical-stage oncology company developing innovative full-length human bispecific and trispecific antibody therapeutics, referred to as Multiclonics®. Multiclonics® are manufactured using industry standard processes and have been observed in preclinical and clinical studies to have several of the same features of conventional human monoclonal antibodies, such as long half-life and low immunogenicity.
OrganisationMerus N.V
HeadquatersUtrecht, Utrecht, Netherlands
Employees117
IndustryHealth Technology
CEOSven Lundberg

Discover more

Frequently Asked Questions

What is Merus N.V (MRUS) share price today?

Can Indians buy Merus N.V (MRUS) shares?

How can I buy Merus N.V (MRUS) shares from India?

Can Fractional shares of Merus N.V (MRUS) be purchased?

What are the documents required to start investing in Merus N.V (MRUS) stocks?